Weighted gene co-expression network analysis (WGCNA) identified genotype-driven, rather than treatment-driven, gene modules, highlighting distinct transcriptional architectures between WT and KO animals
Semaglutide, tirzepatide, and liraglutide are FDA-approved for diabetes and weight management only
Ozempic and Rybelsus are approved for type 2 diabetes, and Wegovy is primarily indicated for weight management in obese and overweight patients, when used along with healthy lifestyle modifications and caloric restrictions
Your provider may also recommend an abdominal assessment if you have a history of gallbladder issues or pancreatitis, as these are relevant safety considerations for GLP-1 therapy
Reduced Risk of Obesity-Related Diseases Lowers the risk of diabetes, heart disease, and high blood pressure
doi: 10.1007/s10753-020-01233-w 168 LinC.-Y.YaoC.-A